Neuphoria Therapeutics Inc. (NEUP) Stock Ticker
Market factors today
Unlock the full NEUP picture
About Neuphoria Therapeutics Inc.
Neuphoria Therapeutics, Inc. is a biotechnology company currently advancing treatments through clinical trials. Its core mission involves pioneering therapies specifically engineered to address the intricate requirements of individuals living with neuropsychiatric disorders. The company was established on December 23, 2024, and its main corporate offices are located in Burlington, Massachusetts.
NEUP stock facts
| Ticker symbol | NEUP |
| Exchange | NASDAQ Global Market |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market cap | $19.7M |
| CEO | Spyridon Papapetropoulos |
| Employees | 1 |
| Headquarters | Burlington, MA, US |
| IPO date | 2021-12-16 |
| Website | www.neuphoriatx.com |
What you can see for NEUP on Tickr
Live NEUP price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the NEUP report.
Rankings
FAQ
What is the ticker symbol for Neuphoria Therapeutics Inc.?
The ticker symbol for Neuphoria Therapeutics Inc. is NEUP, listed on the NASDAQ Global Market.
What is NEUP?
Neuphoria Therapeutics, Inc. is a biotechnology company currently advancing treatments through clinical trials. Its core mission involves pioneering therapies specifically engineered to address the intricate requirements of individuals living with neuropsychiatric disorders. The company was established on December 23, 2024, and its main corporate offices are located in Burlington, Massachusetts.